About Contact Us Careers

Tay-Sachs Disease Treatment Market Size & Share, by Stage (Infantile, Juvenile, Late- Onset); Treatment Type (Physical Therapy, Chest Physiotherapy, Respiratory Care, Antipsychotic Medications); End-user (Hospitals, Homecare, Specialty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 3092
  • Published Date: Dec 26, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Tay-Sachs Disease Treatment Market size was over USD 2.42 billion in 2024 and is poised to exceed USD 4.97 billion by 2037, growing at over 5.7% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of tay-sachs disease treatment is evaluated at USD 2.54 billion.

The growth of the market can be attributed to the growing prevalence of the genetic disease, especially among infants. Tay-Sachs disease is caused by the mutation in HEXA genes, which results into loss of control over muscles. There is no known cure for this disease, therefore, the treatment is generally symptom-specific. Symptoms include exaggerated reactions to loud noises, seizures, loss of movement, vision, and hearing, accumulation of mucus in lungs, and others. The genetic mutation is witnessed specifically in a few communities, such as, eastern and central European Jewish communities, Ashkenazi Jews, certain French-Canadian communities, old order Amish community, and Cajun community, among others. According to the data by the U.S. National Library of Medicine, in this specific Jewish population, one out of every 27 members carry this gene, and one out of every 250-300 live births is affected by Tay- Sachs disease. Rising population of these high-risk communities, is anticipated to boost the market growth. Moreover, increasing investment in R&D activities, to develop new treatment methods to cure the genetic disorder, along with the emergence of new and better drugs used to treat symptoms and complications associated with the disease, are estimated to boost he tay-sachs disease treatment market growth.

Growth Drivers

  • Growing Population of High-Risk Communities
  • High Investment in R&D Activities, to Develop Treatment Methods

Challenges

  • High Cost of Treatment
  • Circulation of Generic Drugs in the Market

Tay-Sachs Disease Treatment Market: Key Insights

Report Attribute Details

Base Year

2024

Forecast Year

2025-2037

CAGR

5.7%

Base Year Market Size (2024)

USD 2.42 billion

Forecast Year Market Size (2037)

USD 4.97 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Tay-Sachs Disease Treatment Segmentation

The tay-sachs disease treatment market is segmented by stage into infantile, juvenile, and late-onset, out of which, the infantile segment is anticipated to gain the largest revenue in the market during the forecast period, as the symptoms are very severe in infantile Tay-Sachs disease, and require immediate and constant treatment. The symptoms appear at 6-months of age, and include vision loss, movement loss, patches inside eyes, and respiratory issues. On the basis of end-user, the market is segmented into hospitals, homecare, specialty clinics, and others, out of which, the specialty clinics segment is projected to witness major growth during the forecast period, owing to the symptom specific, and targeted treatment provided in such clinics.

Our in-depth analysis of the global market includes the following segments:

           Stage
  • Infantile
  • Juvenile
  • Late- Onset

             Treatment Type
  • Physical Therapy
  • Chest Physiotherapy
  • Respiratory Care
  • Antipsychotic Medications
  • Others

 

 

           End-User
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Tay-Sachs Disease Treatment Industry - Regional Synopsis

Regionally, the tay-sachs disease treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America industry is estimated to account for largest revenue share by 2037, on the back of growing cases of Tay-Sachs disease in the region, backed by the high population of Amish, Cajun, and French-Canadian communities, in Pennsylvania, Louisiana, and Quebec, respectively.  Moreover, the advanced healthcare system, along with growing R&D activities in the region, is estimated to boost the market growth. According to the data by the World Health Organization (WHO), as of 2018, 16.416 % of the GDP was spent on the healthcare sector in North America. The tay-sachs disease treatment market in the Middle East and Africa region is also estimated to witness moderate growth over the forecast period, owing to the high Jewish population in Israel, other neighboring countries.

Tay-Sachs Disease Treatment Market Share
Get Strategic Analysis by Region Now: Request Free Sample PDF

Companies Dominating the Tay-Sachs Disease Treatment Landscape

    There is no known cure for Tay-Sachs disease, but treatment is given for the symptoms, which can be different for different patients, and stages. The treatment approach can range from physical therapy, chest physiotherapy, and respiratory care, to antipsychotic medications, and other treatment methods. The major tay-sachs disease treatment market players manufacturing the various kind of drugs needed to treat the symptoms include

    • Sio Gene Therapies Ltd.,
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • F. Hoffmann-La Roche Ltd,
    • Pfizer Inc.,
    • Bayer AG,
    • Bausch Health Companies Inc.,
    • Boehringer Ingelheim International GmbH,
    • AbbVie Inc.,
    • Amgen Inc.,
    • Novartis AG
    • Progenity, Inc.

Recent Developments

· September 9, 2020: Bayer AG to collaborate with Recursion Pharmaceuticals, Inc., to step into research and drug discovery.

  • Report ID: 3092
  • Published Date: Dec 26, 2024
  • Report Format: PDF, PPT
  • Get detailed insights on specific segments/region
  • Inquire about report customization for your industry
  • Learn about our special pricing for startups
  • Request a demo of the report’s key findings
  • Understand the report’s forecasting methodology
  • Inquire about post-purchase support and updates
  • Ask About Company-Level Intelligence Additions

Have specific data needs or budget constraints?

customer-service Inquiry Before Buying

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of tay-sachs disease treatment is evaluated at USD 2.54 billion.

Tay-Sachs Disease Treatment Market size was over USD 2.42 billion in 2024 and is poised to exceed USD 4.97 billion by 2037, growing at over 5.7% CAGR during the forecast period i.e., between 2025-2037.

North America industry is estimated to account for largest revenue share by 2037, on the back of growing cases of Tay-Sachs disease in the region.

The major players in the market are Sio Gene Therapies Ltd, Novartis AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Amgen Inc. and others who manufacture drugs to treat the symptoms of Tay-Sachs disease.

Tay-Sachs Disease Treatment Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos